NCT01725282View on ClinicalTrials.gov

Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

December 14, 2011

Primary Completion Date

August 24, 2013

Study Completion Date

August 24, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

quetiapine extended release (XR)

Extended release tablets

DRUG

Placebo

matching tablets

Trial Locations (3)

Unknown

Hokkaidou

Kantou

Kinki

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY